Synthesis of polyrotaxane-camptothecin conjugates and evaluation of its anti-tumor effect

Yaoxue Xuebao

Volumn 45, Issue 7, 2010, Pages 920-925

  Lai, Chun Li ^a   Lai, Le ^a   Zhao, Jian Bin ^a   Chen, Jian Hai ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Anti tumor effect; Conjugate; Synthesis

Indexed keywords

CAMPTOTHECIN; POLYROTAXANE; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONJUGATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; TUMOR CELL; TUMOR NECROSIS; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLODEXTRINS; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; POLOXAMER; ROTAXANES; SARCOMA 180; TUMOR BURDEN;

EID: 77956484077     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ooya T, Yui N. Synthesis and cracterization of biodegradable polyrotaxane as a novel supramolecular structured drug carrier [J]. J Biomater Sci Polym Edn, 1997, 8: 437-455. (Pubitemid 27196921)
2. Moon C, Kwon YM, Lee WK, et al. A novel polyrootaxane-based intracellular delivery system for camptothecin: in vitro feasibility evaluation [J]. J Biomed Mater Res A, 2008, 84: 238-246. (Pubitemid 350244265)
3. Duchene D, Ponchel G, Wouessidjewe D. Cyclodextrins in targeting-application to nanoparticles [J]. Adv Drug Deliv Rev, 1999, 36: 29-40.
4. Le Ferrec E, Chesne C, Artusson P, et al. In vitro models of intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods [J]. Altern Lab Anim, 2001, 29: 649-668.
5. Harada A, Li J, Kamachi M. Preparation and properties of inclusion complexes of poly(ethylene glycol) with α-cyclodextrin [J]. Macromolecules, 1993, 26: 5698-5703.
6. Xu Q, Wang JJ, Guo J, et al. Apoptosis induced by hydroxycamptothecin in human lung cancer cell SPC-A-1 [J]. Tumor, 2000, 20: 11-12.
7. Chai LP, Su ZZ, Xian ZX. Inhibition of hydroxycamptothecin on laryngeal squamous carcinoma cell line [J]. Chin J Cancer, 2003, 22: 372-375.
8. Ikegam T, MatsuzakY, Al Rashid M, et al. Enhancement of DNA topoisomerase I inhibitor induced apoptosis by ursodeoxycholic acid [J]. Mol Cancer Ther, 2006, 5: 68-79.
9. Zhou YL, Hu WX, Lü YP, et al. Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo [J]. Acta Pharm Sin, 2007, 42: 26-34.
10. Wang HY, Cai B, Cui CB, et al. Vitexicarpin, a flavonoid from Vitex trifolia L., induces apoptosis in K562 cells via mitochondria-controlled apoptotic pathway [J]. Acta Pharm Sin, 2005, 40: 27-31. (Pubitemid 44151787)
11. Li YK. Experimental Methodology of TCM Pharmacology [M]. Shanghai: Shanghai Science and Technology Press, 1991: 512-513.
12. Gong ZJ, Zhan RZ. Pathological Tissues Preparation and Staining Technology [M]. Shanghai: Shanghai Science and Technology Press, 1994: 296-302.